Recombinant Protective Antigen Anthrax Vaccine Improves Survival When Administered as a Postexposure Prophylaxis Countermeasure With Antibiotic in the New Zealand White Rabbit Model of Inhalation Anthrax
Clinical and Vaccine Immunology - United States
doi 10.1128/cvi.00240-12
Full Text
Open PDFAbstract
Available in full text
Date
June 13, 2012
Authors
Publisher
American Society for Microbiology